WW International (WW)
Market Price (6/7/2026): $16.36 | Market Cap: $163.5 MilSector: Health Care | Industry: Health Care Facilities
WW International (WW)
Market Price (6/7/2026): $16.36Market Cap: $163.5 MilSector: Health CareIndustry: Health Care Facilities
Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.
Attractive yieldTotal YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 663%, ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is 659% Valuation becoming less expensiveP/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is -43% Megatrend and thematic driversMegatrends include Health & Wellness Trends, Aging Population & Chronic Disease, and Digital Health & Telemedicine. Themes include Weight Management Programs, Show more. | Weak multi-year price returns2Y Excs Rtn is -99%, 3Y Excs Rtn is -136% Meaningful short interestShort Interest % of Basic SharesShort Interest % of Basic Shares = (Short Interest Quantity) / (Basic Shares Outstanding). A high fraction of short interest can indicate potential risk of a short squeeze. is 19% | Debt is significantNet D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is 214% Weak revenue growthRev Chg QQuarterly Revenue Change % is -9.8% Not cash flow generativeCFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is -11%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is -14% Key risksWW key risks include [1] its core subscriber base and business model being directly undermined by the rise of GLP-1 weight loss drugs, Show more. |
| Attractive yieldTotal YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 663%, ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is 659% |
| Valuation becoming less expensiveP/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is -43% |
| Megatrend and thematic driversMegatrends include Health & Wellness Trends, Aging Population & Chronic Disease, and Digital Health & Telemedicine. Themes include Weight Management Programs, Show more. |
| Weak multi-year price returns2Y Excs Rtn is -99%, 3Y Excs Rtn is -136% |
| Meaningful short interestShort Interest % of Basic SharesShort Interest % of Basic Shares = (Short Interest Quantity) / (Basic Shares Outstanding). A high fraction of short interest can indicate potential risk of a short squeeze. is 19% |
| Debt is significantNet D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is 214% |
| Weak revenue growthRev Chg QQuarterly Revenue Change % is -9.8% |
| Not cash flow generativeCFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is -11%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is -14% |
| Key risksWW key risks include [1] its core subscriber base and business model being directly undermined by the rise of GLP-1 weight loss drugs, Show more. |
Qualitative Assessment
AI Analysis | Feedback
WW International (WW) stock has lost about 25% since 2/28/2026 because of the following key factors:
1. Q1 2026 Earnings Miss and Revenue Decline. WW International reported a significant earnings miss for Q1 2026, with a loss per share of -$5.20, far exceeding the consensus estimate of -$2.52 by 106.34%. Total revenue for the quarter was $168 million, a 10% decrease year-over-year. This performance led to a premarket stock drop of 15.76% following the announcement on May 7, 2026, with some sources indicating a 22.3% drop in the session.
2. Continued Decline in Behavioral Subscriber Base Amidst GLP-1 Competition. The company's traditional behavioral subscriber base continued to shrink, with end-of-period behavioral subscribers declining by 25% year-over-year to 2.5 million in Q1 2026. This resulted in a 17% year-over-year decline in behavioral subscription revenue. This ongoing trend is largely attributed to "secular headwinds" and increasing consumer interest in GLP-1 (glucagon-like peptide-1) weight-loss medications, which are disrupting the traditional weight management market.
Show more
Stock Movement Drivers
Fundamental Drivers
The -23.6% change in WW stock from 2/28/2026 to 6/6/2026 was primarily driven by a 0.0% change in the company's Shares Outstanding (Mil).| (LTM values as of) | 2282026 | 6062026 | Change |
|---|---|---|---|
| Stock Price ($) | 21.26 | 16.25 | -23.6% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | � | � | 0.0% |
| Net Income Margin (%) | � | � | 0.0% |
| P/E Multiple | � | � | 0.0% |
| Shares Outstanding (Mil) | 80 | 80 | 0.0% |
| Cumulative Contribution | 0.0% |
Market Drivers
2/28/2026 to 6/6/2026| Return | Correlation | |
|---|---|---|
| WW | -23.6% | |
| Market (SPY) | 7.8% | 35.5% |
| Sector (XLV) | -4.1% | 24.6% |
Fundamental Drivers
The -42.7% change in WW stock from 11/30/2025 to 6/6/2026 was primarily driven by a 0.0% change in the company's Shares Outstanding (Mil).| (LTM values as of) | 11302025 | 6062026 | Change |
|---|---|---|---|
| Stock Price ($) | 28.37 | 16.25 | -42.7% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | � | � | 0.0% |
| Net Income Margin (%) | � | � | 0.0% |
| P/E Multiple | � | � | 0.0% |
| Shares Outstanding (Mil) | 80 | 80 | 0.0% |
| Cumulative Contribution | 0.0% |
Market Drivers
11/30/2025 to 6/6/2026| Return | Correlation | |
|---|---|---|
| WW | -42.7% | |
| Market (SPY) | 8.5% | 36.1% |
| Sector (XLV) | -2.1% | 17.9% |
Fundamental Drivers
nullnull
Market Drivers
5/31/2025 to 6/6/2026| Return | Correlation | |
|---|---|---|
| WW | ||
| Market (SPY) | 26.6% | 32.2% |
| Sector (XLV) | 17.4% | 20.0% |
Fundamental Drivers
nullnull
Market Drivers
5/31/2023 to 6/6/2026| Return | Correlation | |
|---|---|---|
| WW | ||
| Market (SPY) | 83.4% | 32.2% |
| Sector (XLV) | 25.8% | 20.0% |
Price Returns Compared
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Total [1] | |
|---|---|---|---|---|---|---|---|
| Returns | |||||||
| WW Return | - | - | - | - | -27% | -41% | -57% |
| Peers Return | -4% | -24% | 25% | 15% | -5% | -24% | -24% |
| S&P 500 Return | 27% | -19% | 24% | 23% | 16% | 11% | 102% |
Monthly Win Rates [3] | |||||||
| WW Win Rate | - | - | - | - | 50% | 50% | |
| Peers Win Rate | 52% | 40% | 53% | 47% | 38% | 40% | |
| S&P 500 Win Rate | 75% | 42% | 67% | 75% | 67% | 67% | |
Max Drawdowns [4] | |||||||
| WW Max Drawdown | - | - | - | - | - | -74% | |
| Peers Max Drawdown | -40% | -47% | -35% | -45% | -51% | -49% | |
| S&P 500 Max Drawdown | -5% | -25% | -10% | -8% | -19% | -9% | |
[1] Cumulative total returns since the beginning of 2021
[2] Peers: MED, HLF, BRBR, SMPL, HIMS. See WW Returns vs. Peers.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2026 data is for the year up to 6/5/2026 (YTD)
How Low Can It Go
WW has limited trading history. Below is the Health Care sector ETF (XLV) in its place.
| Event | XLV | S&P 500 |
|---|---|---|
| 2025 US Tariff Shock | ||
| % Loss | -11.7% | -18.8% |
| % Gain to Breakeven | 13.3% | 23.1% |
| Time to Breakeven | 142 days | 79 days |
| 2022 Inflation Shock & Fed Tightening | ||
| % Loss | -13.8% | -24.5% |
| % Gain to Breakeven | 15.9% | 32.4% |
| Time to Breakeven | 166 days | 427 days |
| 2020 COVID-19 Crash | ||
| % Loss | -27.9% | -33.7% |
| % Gain to Breakeven | 38.8% | 50.9% |
| Time to Breakeven | 77 days | 140 days |
| Q4 2018 Fed Policy Error / Growth Scare | ||
| % Loss | -15.0% | -19.2% |
| % Gain to Breakeven | 17.6% | 23.8% |
| Time to Breakeven | 191 days | 105 days |
| 2015-2016 China Devaluation / Global Growth Scare | ||
| % Loss | -15.9% | -12.2% |
| % Gain to Breakeven | 18.9% | 13.9% |
| Time to Breakeven | 165 days | 62 days |
| 2011 US Debt Ceiling Crisis & European Contagion | ||
| % Loss | -15.8% | -17.9% |
| % Gain to Breakeven | 18.8% | 21.8% |
| Time to Breakeven | 153 days | 123 days |
In The Past
State Street Health Care Select Sector SPDR ETF's stock fell -11.7% during the 2025 US Tariff Shock. Such a loss loss requires a 13.3% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
WW has limited trading history. Below is the Health Care sector ETF (XLV) in its place.
| Event | XLV | S&P 500 |
|---|---|---|
| 2020 COVID-19 Crash | ||
| % Loss | -27.9% | -33.7% |
| % Gain to Breakeven | 38.8% | 50.9% |
| Time to Breakeven | 77 days | 140 days |
| 2008-2009 Global Financial Crisis | ||
| % Loss | -37.9% | -53.4% |
| % Gain to Breakeven | 61.1% | 114.4% |
| Time to Breakeven | 767 days | 1085 days |
In The Past
State Street Health Care Select Sector SPDR ETF's stock fell -11.7% during the 2025 US Tariff Shock. Such a loss loss requires a 13.3% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
About WW International (WW)
AI Analysis | Feedback
Here are a few analogies for WW International (symbol: WW):
- Peloton for weight management. (Like Peloton's subscription-based, community-driven, and digitally supported approach to fitness, WW provides a similar model for weight loss and wellness.)
- Nike for nutrition and wellness. (Similar to Nike's brand offering a lifestyle, programs, and supporting consumer products for athletics, WW offers a holistic program and branded products for healthy living.)
AI Analysis | Feedback
- Digital Weight Management Subscriptions: These products offer interactive and personalized resources through an app and web platform, including personal coaching and a supportive community.
- Consumer Products: WW offers various branded consumer products such as bars, snacks, cookbooks, and kitchen tools.
- Trademark Licensing: The company licenses its trademarks and other intellectual property for use on food, beverages, and other relevant consumer products and services.
- Publishing Services: WW also provides publishing services.
AI Analysis | Feedback
WW International (symbol: WW) primarily sells its products and services to individuals. Based on the company description, its major customer categories are:
-
Active Program Participants (Subscribers): Individuals who subscribe to WW's digital weight management programs, app, web-based products, and personal coaching services. These customers are actively engaged in following the WW plan for weight loss, wellness, and often seek the interactive resources and community support provided by the platform.
-
Consumers of WW-Branded Products: Individuals who purchase WW's various consumer products, including bars, snacks, cookbooks, and kitchen tools. These customers may or may not be active subscribers to the weight management program but are interested in health-conscious products aligned with the WW brand, often purchased through e-commerce platforms or partners.
AI Analysis | Feedback
Salesforce, Inc. (CRM)
AI Analysis | Feedback
Tara Comonte, President and Chief Executive Officer
Ms. Comonte has served as President and Chief Executive Officer since February 2025, having previously been the Interim President and Chief Executive Officer from September 2024 to February 2025. She has been a director since June 2023. Ms. Comonte brings over two decades of executive leadership experience spanning corporate and digital strategy, technology, operations, and finance, having navigated a diverse range of industries and complex business transitions.
Felicia DellaFortuna, Chief Financial Officer
Ms. DellaFortuna was appointed Chief Financial Officer, effective January 1, 2025. She previously served as Chief Financial Officer at Enthusiast Gaming and BuzzFeed, Inc. At BuzzFeed, she played a key role in its transformation into a profitable digital media company, diversifying revenue streams, enhancing growth strategies, and leading corporate development initiatives, including acquisitions. Earlier in her career, she held senior finance roles at Viant Technology Inc. and XIX Entertainment, and began her career in Transaction Advisory Services and Audit at Ernst & Young. She is a Certified Public Accountant.
Jacqueline Cooke, Chief Legal and Administrative Officer and Secretary
Ms. Cooke has served as Chief Legal and Administrative Officer and Secretary since March 2025, following her roles as Chief Legal and Regulatory Officer and Secretary (August 2024 to March 2025) and General Counsel and Secretary (March 2024 to July 2024). Prior to joining WW International, she was the General Counsel & Privacy Officer at 23andMe Holding Co. from February 2022 to January 2024.
Alejandro Bethlen, Executive Vice President, International
Mr. Bethlen has served as Executive Vice President, International, since September 2025. In this role, he oversees the company's international business across Europe, APAC, and emerging markets. He brings over two decades of experience scaling global consumer, e-commerce, and marketplace businesses. Before joining WeightWatchers, Mr. Bethlen was the Chief Merchandising Officer and Executive Committee Member at Zooplus SE, Europe's largest online pet platform.
Julie Rice, Chief Experience Officer
Ms. Rice is the Chief Experience Officer at WeightWatchers, where she leads community and brand innovation. An entrepreneur, she is best known for co-founding SoulCycle, where she served as Co-CEO from 2006 to 2015. She was also a Partner at WeWork from 2017 to 2019.
AI Analysis | Feedback
Key Risks to WW International (WW)
- Disruption from GLP-1 Weight Loss Medications: WW International faces a significant risk from the increasing popularity and effectiveness of GLP-1 (glucagon-like peptide-1) weight loss drugs. These medications are disrupting the company's traditional behavioral weight management programs, leading to a shrinking subscriber base in its legacy segments. WW's future success is heavily reliant on the growth of its clinical segment to counteract these declines.
- Financial Instability and Debt Load: Despite a recent financial reorganization in February 2025, which included filing for Chapter 11 bankruptcy protection to eliminate a substantial portion of its debt, uncertainty persists regarding the sustainability of WW's business model and its ability to reverse subscriber and revenue declines. Prior to the restructuring, the company's high debt levels were a significant concern for investors, and S&P Global Ratings downgraded WW due to elevated default risk. The company's ability to generate sufficient cash flow to service its remaining debt and meet liquidity requirements remains a key risk.
- Intense Competition and Declining Subscriber Engagement: WW International operates in an intensely competitive market, facing challenges from various weight management programs, digital health platforms, and large tech companies entering the wellness space. The company has struggled to maintain its brand relevance, particularly among younger consumers like Millennials and Gen Z, leading to a decline in overall subscribers and revenue. The inability to effectively attract and retain subscribers poses a continuous threat to the company's growth and profitability.
AI Analysis | Feedback
The emergence and increasing adoption of GLP-1 agonist drugs (e.g., Ozempic, Wegovy, Mounjaro) for weight loss represents a significant emerging threat. These highly effective medical interventions could fundamentally alter the demand for traditional behavioral and dietary weight management programs that form the core of WW's business model. As more individuals opt for pharmaceutical solutions, the market for WW's digital subscriptions, coaching, and lifestyle-based approaches to weight management may contract or undergo a substantial shift in consumer preference.
AI Analysis | Feedback
WW International, Inc. operates in several substantial addressable markets globally and across its key regions.Weight Management Products and Services
The global weight management market was estimated at USD 142.58 billion in 2022 and is projected to reach USD 298.66 billion by 2030, growing at a compound annual growth rate (CAGR) of 9.94% from 2023 to 2030. * North America: The weight management market in North America generated USD 37,534.9 million in revenue in 2022 and is expected to reach USD 81,106.2 million by 2030, growing at a CAGR of 10.1% from 2023 to 2030. * Europe: The Europe weight management market size was valued at USD 136.34 billion in 2024 and is expected to reach USD 220.75 billion by 2033, exhibiting a CAGR of 5.22% during 2025-2033. * United Kingdom: The UK weight management market generated a revenue of USD 3,314.9 million in 2022 and is expected to reach USD 4,671.8 million by 2030.Digital Subscription Products (Digital Health and Wellness)
The digital health and wellness market, which includes digital weight management solutions, represents a significant addressable market. * Global: The global digital health and wellness market size was calculated at USD 498.99 billion in 2024, grew to USD 607.06 billion in 2025, and is projected to reach around USD 3,568.11 billion by 2034, expanding at a CAGR of 21.92% between 2025 and 2034. * North America: North America dominated the digital health and wellness market in 2024. The mHealth market in North America, a component of digital health, was USD 61.74 billion in 2020 and is expected to reach USD 261.53 billion by 2026. * Europe: The mHealth market in Europe was USD 50.89 billion in 2020 and is expected to reach USD 227.43 billion by 2026. The Europe Digital Health for Obesity Market is projected to witness market growth of 23.1% CAGR during the forecast period (2025-2032). * United Kingdom: The UK digital health for obesity market is exhibiting a CAGR of 21.8% during 2025-2032.Consumer Products (Bars, Snacks, Cookbooks, Kitchen Tools)
* Healthy Food: * Global: The global healthy food market size reached USD 784.19 billion in 2025 and is predicted to increase to nearly USD 2,052.55 billion by 2035, growing at a CAGR of 10.1% over the forecast period from 2026 to 2035. * North America (Health & Wellness Foods): The North America health & wellness foods market was the largest market with revenue of USD 338.8 billion in 2025. * Healthy Snacks: * Global: The global healthy snacks market size is estimated at USD 108.34 billion in 2025 and is predicted to increase to approximately USD 195.20 billion by 2035, expanding at a CAGR of 4.95% from 2025 to 2034. * North America: North America led the global healthy snacks market, commanding 35.3% of the total market share in 2025. * Cookbooks (Paper Cookbooks): * Global: The global paper cookbook market is valued at approximately USD 4.8 billion in 2024 and is anticipated to reach around USD 6.9 billion by 2033. * Kitchen Tools: * Global: The global kitchen tools & accessories market was estimated at USD 374.3 billion in 2024 and is expected to reach around USD 553.4 billion by 2034, growing at a CAGR of 4.1%.AI Analysis | Feedback
WW International (symbol: WW) is strategically repositioning itself to drive future revenue growth over the next 2-3 years, focusing on an integrated approach that combines behavioral support with clinical care. Key drivers for this anticipated growth include:
-
Expansion of Clinical Weight Management Services and GLP-1 Integration: WW International is making a significant pivot to become a telehealth provider, integrating GLP-1-based weight loss medications with its digital health solutions and behavioral programs. This strategic transformation is expected to be a monumental driver, with clinical revenue already showing substantial year-over-year growth.
-
Digital Transformation and Unified Platform: The company is undertaking a complete digital overhaul of its WeightWatchers app and website. This replatforming aims to remove existing barriers between its clinical and behavioral offerings, creating a seamless and integrated experience for members. This unified digital ecosystem is expected to enhance engagement and support future growth.
-
Strategic Partnerships with Payers, Employers, and Pharmaceutical Companies: WW International is actively forging partnerships to expand access to its services. Collaborations with pharmaceutical players (such as Novo Nordisk and Amazon Pharmacy for drug delivery) and efforts to make WeightWatchers a covered benefit through employers and payers are expected to drive clinical subscriber growth and overall revenue.
-
Growth in High Lifetime Value (LTV) Clinical Subscribers: While overall subscriber numbers have seen some fluctuations, the clinical subscriber segment is growing and is noted for having a significantly higher lifetime value and revenue per paid week compared to digital and workshop subscribers. The company aims to increase its clinical subscriber base, which will contribute disproportionately to revenue growth.
AI Analysis | Feedback
Capital Allocation Decisions (2021-2025)
Share Repurchases
- WW International made no share repurchases during the three months ended March 29, 2025, or March 30, 2024.
Share Issuance
- On June 24, 2025, WW International's existing shares were canceled, and 10 million new shares of common stock were issued as part of a reorganization plan.
- Prior to the reorganization, on April 29, 2025, the number of common stock outstanding was 80,280,308 shares.
Inbound Investments
- In November 2025, Director Carney Hawks purchased 29,057 shares of WW International stock for a total value of $643,385.
- Institutional investors actively traded WW stock in Q4 2025, with 50 adding shares and 44 decreasing their positions.
Outbound Investments
- In April 2023, WW International acquired Weekend Health Inc., doing business as Sequence, a provider of healthcare management services.
Capital Expenditures
- Capital expenditures for Q3 2025 totaled $3 million.
- In Q1 2025, capital expenditures were $5 million, and capitalized software and website development expenditures were $3.17 million.
- Capital expenditures increased by approximately $19.9 million in 2024, primarily focused on building the clinical platform.
- For 2026, capital expenditures are expected to increase and return toward historical levels, driven by higher investment in product and technology innovation.
Latest Trefis Analyses
Research & Analysis
Invest in Strategies
Wealth Management
Peer Comparisons
| Peers to compare with: |
Financials
| Median | |
|---|---|
| Name | |
| Mkt Price | 12.02 |
| Mkt Cap | 1.1 |
| Rev LTM | 1,874 |
| Op Inc LTM | 95 |
| FCF LTM | 103 |
| FCF 3Y Avg | 174 |
| CFO LTM | 184 |
| CFO 3Y Avg | 214 |
Growth & Margins
| Median | |
|---|---|
| Name | |
| Rev Chg LTM | 3.7% |
| Rev Chg 3Y Avg | 6.1% |
| Rev Chg Q | -3.8% |
| QoQ Delta Rev Chg LTM | -0.9% |
| Op Inc Chg LTM | -32.8% |
| Op Inc Chg 3Y Avg | 4.4% |
| Op Mgn LTM | 5.5% |
| Op Mgn 3Y Avg | 8.5% |
| QoQ Delta Op Mgn LTM | -1.2% |
| CFO/Rev LTM | 8.5% |
| CFO/Rev 3Y Avg | 10.4% |
| FCF/Rev LTM | 4.9% |
| FCF/Rev 3Y Avg | 7.1% |
Valuation
| Median | |
|---|---|
| Name | |
| Mkt Cap | 1.1 |
| P/S | 0.4 |
| P/Op Inc | 3.0 |
| P/EBIT | -4.0 |
| P/E | -3.3 |
| P/CFO | 5.8 |
| Total Yield | 7.6% |
| Dividend Yield | 0.0% |
| FCF Yield 3Y Avg | 7.3% |
| D/E | 0.8 |
| Net D/E | 0.7 |
Returns
| Median | |
|---|---|
| Name | |
| 1M Rtn | -4.3% |
| 3M Rtn | -25.7% |
| 6M Rtn | -32.9% |
| 12M Rtn | -56.4% |
| 3Y Rtn | -63.1% |
| 1M Excs Rtn | -5.3% |
| 3M Excs Rtn | -35.3% |
| 6M Excs Rtn | -41.0% |
| 12M Excs Rtn | -78.9% |
| 3Y Excs Rtn | -139.8% |
Price Behavior
| Market Price | $16.25 | |
| Market Cap ($ Bil) | 0.2 | |
| First Trading Date | 11/15/2001 | |
| Distance from 52W High | -63.8% | |
| 50 Days | 200 Days | |
| DMA Price | $28.12 | $28.12 |
| DMA Trend | down | down |
| Distance from DMA | -42.2% | -42.2% |
| 3M | 1YR | |
| Volatility | 121.8% | 92.7% |
| Downside Capture | 614.85 | 418.30 |
| Upside Capture | 288.57 | 203.73 |
| Correlation (SPY) | 34.3% |
| 1M | 2M | 3M | 6M | 1Y | 3Y | |
|---|---|---|---|---|---|---|
| Beta | 7.80 | 4.24 | 2.91 | 2.93 | 0.37 | -0.80 |
| Up Beta | 2.02 | -0.98 | 0.15 | 1.93 | 0.67 | 0.06 |
| Down Beta | 2.95 | 4.48 | 1.24 | 2.22 | 0.94 | 0.19 |
| Up Capture | 1473% | 656% | 416% | 332% | 267% | 25% |
| Bmk +ve Days | 13 | 28 | 36 | 67 | 141 | 432 |
| Stock +ve Days | 11 | 21 | 31 | 56 | 105 | 105 |
| Down Capture | 1043% | 1116% | 421% | 287% | 205% | 103% |
| Bmk -ve Days | 7 | 13 | 27 | 57 | 109 | 318 |
| Stock -ve Days | 8 | 19 | 31 | 67 | 118 | 118 |
[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
Based On 1-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with WW | |
|---|---|---|---|---|
| WW | -59.5% | 92.7% | -0.65 | - |
| Sector ETF (XLV) | 16.9% | 15.0% | 0.83 | 20.0% |
| Equity (SPY) | 25.3% | 12.1% | 1.57 | 32.2% |
| Gold (GLD) | 27.6% | 26.9% | 0.88 | 9.9% |
| Commodities (DBC) | 36.9% | 19.0% | 1.52 | -8.2% |
| Real Estate (VNQ) | 12.5% | 13.3% | 0.63 | 12.4% |
| Bitcoin (BTCUSD) | -42.0% | 42.5% | -1.16 | 22.5% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 5-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with WW | |
|---|---|---|---|---|
| WW | -16.5% | 92.7% | -0.65 | - |
| Sector ETF (XLV) | 6.1% | 14.7% | 0.23 | 20.0% |
| Equity (SPY) | 13.5% | 17.1% | 0.62 | 32.2% |
| Gold (GLD) | 17.3% | 18.1% | 0.78 | 9.9% |
| Commodities (DBC) | 9.5% | 19.4% | 0.38 | -8.2% |
| Real Estate (VNQ) | 3.2% | 18.8% | 0.07 | 12.4% |
| Bitcoin (BTCUSD) | 11.3% | 54.6% | 0.40 | 22.5% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 10-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with WW | |
|---|---|---|---|---|
| WW | -8.6% | 92.7% | -0.65 | - |
| Sector ETF (XLV) | 9.9% | 16.6% | 0.48 | 20.0% |
| Equity (SPY) | 15.3% | 17.9% | 0.73 | 32.2% |
| Gold (GLD) | 13.0% | 16.0% | 0.67 | 9.9% |
| Commodities (DBC) | 7.1% | 18.0% | 0.32 | -8.2% |
| Real Estate (VNQ) | 5.6% | 20.7% | 0.24 | 12.4% |
| Bitcoin (BTCUSD) | 63.3% | 66.9% | 1.03 | 22.5% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Returns Analyses
Recent Forward Guidance
Updated 6/1/2026Latest: Q1 2026 Earnings Reported 5/7/2026
| Forward Guidance | Guidance Change | ||||||
|---|---|---|---|---|---|---|---|
| Metric | Low | Mid | High | % Chg | % Delta | Change | Prior |
| Q2 2026 Term Loan Prepayment | 37.00 Mil | Higher New | |||||
| 2026 Revenue | 620.00 Mil | 627.50 Mil | 635.00 Mil | 0 | Affirmed | Guidance: 627.50 Mil for 2026 | |
| 2026 Adjusted EBITDA | 105.00 Mil | 110.00 Mil | 115.00 Mil | 0 | Affirmed | Guidance: 110.00 Mil for 2026 | |
| 2026 Debt Reduction | 42.00 Mil | Higher New | |||||
| 2026 Annualized Interest Expense Reduction | 4.00 Mil | Higher New | |||||
Prior: Q4 2025 Earnings Reported 3/16/2026
| Forward Guidance | Guidance Change | ||||||
|---|---|---|---|---|---|---|---|
| Metric | Low | Mid | High | % Chg | % Delta | Change | Prior |
| Q1 2026 Total End of Period Subscribers | 2.65 Mil | ||||||
| Q1 2026 End of Period Clinical Subscribers | 0.20 Mil | ||||||
| 2026 Revenue | 620.00 Mil | 627.50 Mil | 635.00 Mil | -10.0% | Lowered | Guidance: 697.50 Mil for 2025 | |
| 2026 Adjusted EBITDA | 105.00 Mil | 110.00 Mil | 115.00 Mil | -25.4% | Lowered | Guidance: 147.50 Mil for 2025 | |
Insider Activity
Updated 5/27/2026| # | Owner | Title | Holding | Action | Filing Date | Price | Shares | Transacted Value | Value of Held Shares | Form |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Davis, Eugene I | Direct | Buy | 5272026 | 14.73 | 10,000 | 147,329 | 318,938 | Form | |
| 2 | Davis, Eugene I | Direct | Buy | 5272026 | 13.48 | 1,648 | 22,218 | 157,034 | Form | |
| 3 | Dellafortuna, Felicia | CFO & Member, IOCE | Direct | Buy | 5272026 | 12.68 | 1,500 | 19,012 | 19,012 | Form |
| 4 | Davis, Eugene I | Direct | Buy | 5272026 | 12.63 | 10,000 | 126,251 | 126,251 | Form | |
| 5 | Volkmann, Jonathan | Chief Ops Off. & Member, IOCE | Direct | Buy | 5212026 | 10.08 | 1,500 | 15,120 | 32,216 | Form |
External Quote Links
| Y Finance | Barrons |
| TradingView | Morningstar |
| SeekingAlpha | ValueLine |
| Motley Fool | Robinhood |
| CNBC | Etrade |
| MarketWatch | Unusual Whales |
| YCharts | Perplexity Finance |
| FinViz |
Prefer one of these to Trefis? Tell us why.